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Background: Acupuncture has been widely used as a treatment for stroke in China for more than 3,000 years.
However, previous research has not yet shown that acupuncture is effective as a stroke treatment. We report a
protocol for a multicenter, randomized, controlled, and outcome assessor-blind trial to evaluate the efficacy and
safety of acupuncture on acute ischemic stroke.
Methods/Design: In a prospective trial involving three hospitals in the Zhejiang Province (China) 250 patients with
a recent (less than 1 week previous) episode of ischemic stroke will be included. Patients will be randomized into
two groups: an acupuncture group given scalp acupuncture and electroacupuncture, and a control group given no
acupuncture. Eighteen treatment sessions will be performed over a three-week period. The primary outcome will
be measured by changes in the National Institutes of Health Stroke Scale score at the one, three, and four-week
follow-up. Secondary outcome measures will be: 1) the Fugl-Meyer assessment scale for motor function; 2) the
mini-mental state examination and Montreal cognitive assessment for cognitive function; 3) the video-fluoroscopic
swallowing study for swallowing ability; and 4) the incidence of adverse events.
Discussion: This trial is expected to clarify whether or not acupuncture is effective for acute stroke. It will also show
if acupuncture can improve motor, cognitive, or swallowing function.
Trial registration: Chinese Clinical Trial Registry ChiCTR-TRC-12001971.
Keywords: Acupuncture, Stroke, Multicenter RCTBackground
Stroke is a major cause of death and disability worldwide
[1-3]. It is also the leading cause of death and long-term
disability in China [4,5], where a rising incidence of stroke
has created a serious public health problem [6,7]. Despite
a considerable amount of research on treatment for stroke
there is still no single intervention that clearly and defin-
itely contributes to stroke recovery. However, there is no
doubt that the treatment of stroke should be combined
with multiple disciplines such as neurology, rehabilitation
medicine, and traditional medicine. Acupuncture has been* Correspondence: fangjianqiao7532@163.com
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unless otherwise stated.used in traditional Chinese medicine for more than 3,000
years as a treatment for many diseases and is especially
well accepted in China for post-stroke rehabilitation [8].
Because stroke is one of the most common uses of acu-
puncture therapy, many Chinese acupuncture depart-
ments have set up special wards to treat stroke patients to
maximize the promotion of recovery. It has been shown
that acupuncture can cause multiple biological responses
including circulatory and biochemical effects [9,10]. As a
therapeutic intervention acupuncture is used to improve
motor, sensation, speech, swallowing, cognitive, and other
neurological functions in patients with stroke [11,12].
Scalp acupuncture seems to improve the neurological
deficit score and clinical effective rate when compared
with Western conventional medicines alone [13], and it
produces positive but limited effectiveness as an adjunct
treatment to conventional care [14]. Electroacupuncturetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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patients with acute ischemic stroke and is generally safe
[15]. However, Cochrane reviews have shown that while
acupuncture appears to be safe, there is no clear evidence
of benefit [16]. Therefore, there is insufficient data on the
routine usage of acupuncture in acute stroke. More rigor-
ously designed, large, multicenter, randomized trials are




The study is a prospective, multicenter, outcome assessor-
blinded, randomized controlled clinical trial carried out in
three inpatient stroke rehabilitation units. After the inclu-
sion and consent of the Institutional Review Board, par-
ticipants will be randomized to either the control (no
acupuncture) or the acupuncture group. The control group
will receive conventional stroke rehabilitation care (includ-
ing physical and occupational therapy, swallowing training
for dysphagia, and/or cognitive training for cognitive im-
pairment; six days per week) during the inpatient stay. The
acupuncture group will receive conventional stroke reha-
bilitation care and 30 additional minutes of acupuncture
therapy six days per week for three weeks (18 total acu-
puncture sessions) during the inpatient stay. The trial de-
sign is summarized in Figure 1.Figure 1 Flow diagram of study design.Participant recruitment
Participants will be recruited in three large hospitals
(The Second Hospital of Jiaxing City, Sir Run Run Shaw
Hospital, and The First People’s Hospital of Hangzhou)
in Zhejiang Province, China. Our study will be propa-
gated by local newspapers, health-related TV programs,
the internet, and posters in communities and hospitals.
Prospective participants will be asked to talk face-to-face
with study coordinators to discuss the study and provide
information regarding eligibility criteria. If patients are
eligible and interested in participating they will be invited
for a series of rehabilitation assessments after diagnosis by
neurologists. Two hundred and fifty consecutive patients
admitted to the three hospitals because of acute ischemic
stroke will be included in the study. When their informed
consent has been obtained, patients will be randomized
into two groups with different treatments.
Inclusion criteria
We will choose patients aged between 35 and 80-years-
old who are hospitalized with acute ischemic stroke
according to the criteria of both Western medicine and
traditional Chinese medicine. The stroke onset must be
between two to seven days beforehand, with a National
Institutes of Health Stroke Scale (NIHSS) score of be-
tween 4 and 24. The stroke should be the first incidence
or patients can have a history of stroke but without
disability (modified Rankin Scale, mRS score ≤1).
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Patients who received thrombolytic therapy or who
participated in other clinical trials within last three
months are not included. Patients who suffered from
serious heart,liver,kidney related diseases, blood coagula-
tion dysfunction, or severe mental disorders will not be
included. Women who are pregnant or breast-feeding
and patients with a severe cognitive impairment are
also excluded.
Ethical considerations
Each ethics committee of the Third Affiliated Hospital
of Zhejiang Chinese Medical University, The Second
Hospital of Jiaxing City, and Sir Run Run Shaw Hospital,
together with The First People’s Hospital of Hangzhou,
all approved the study. The purpose, nature, and poten-
tial risks of the experiments were fully explained to the
patients and their families. All patients gave their written
informed consent before participating in the study.
Randomization and blinding
Randomization to acupuncture or no acupuncture will
be computer-generated by independent research staff
using software. The treatment codes are placed in sealed
opaque envelopes which will be distributed by research
nurses who will be trained before the trial and will not
participate in treatment or nursing. Patients in this re-
search will be told that they will receive routine reha-
bilitation treatment with or without acupuncture. It is
impossible to blind the acupuncturists because they
must be trained to perform the acupuncture according
to the research plan. A special rehabilitation doctor from
each center will be assigned to be the assessor who is
blinded to the patient treatment group and does not
participate in the treatment of subjects. All study
personnel including the rehabilitation therapists, out-
come assessors, and data analysts will be blinded to
group assignments.
Interventions and comparison
The study is a randomized clinical trial carried out in
three inpatient rehabilitation departments of three hos-
pitals. Participants will be randomized to either the con-
trol or the acupuncture group. Both groups will receive
conventional stroke rehabilitation care, which begins as
soon as the diagnosis of stroke is established and life-
threatening problems are under control. The basic rehabili-
tation care includes normal limb posture, passive motion
with hemiplegia side, bedside rehabilitation (Bobath tech-
nique, overturning movement, bridge movement), and/or
neuromuscular electrical stimulation, swallow training for
dysphagia, and/or cognitive training for cognitive impair-
ment. The rehabilitation program (including physiotherapy
and occupational therapy for two hours per day, six daysper week) of each participant will be developed by the re-
habilitation team according to the investigator’s brochure.
The acupuncture group will receive 30 additional minutes
of acupuncture therapy for six days per week for three
weeks (18 total sessions) during the inpatient stay.Acupuncture group
The acupuncture protocol is designed by a professor from
Zhejiang Chinese Medical University who has more than
20 years of practice experience, and will be performed by
three doctors from the acupuncture department who have
a master’s degree with more than five years of clinical ex-
perience. They will be trained together and use the same
techniques. The treatment will be started in both groups
after randomization. The acupuncture protocol is split
according to the area of treatment.
The parameters for scalp acupuncture are set as follows:
two to three needles penetrating through the top midline,
the motor region, and the sensory region of the lesion
side. The parameters for the affected side of the body are
as follows: LI15 (Jian Yu), LI11 (Qu Chi), LI10 (Shou San
Li), SJ5 (Wai Guan), LI4 (He Gu) for upper extremities;
St34 (Liang Qiu), St36 (Zu San Li), GB34 (Yang Ling
Quan), Sp6 (San Yin Jiao), St40 (Feng Long), St41 (Jie Xi),
and Liv3 (Tai Chong) for lower limbs. The parameters for
acupoint modification are set as follows: For dysphagia,
GB20 (Feng Chi), EX-HN14 (Yi Ming), BL10 (Tian Zhu),
DU16 (Feng Fu), Gong Xue (1 cun below GB20), RN23
(Lian Quan) will be added. For mild cognitive impairment,
DU20 (Bai Hui), DU24 (Shen Ting), GB13 (Ben Shen),
EX-HN1 (Si Shen Cong) will be added.
Manual stimulation will be applied to the body acu-
points until the patients experience De qi (get Qi).
Patients experience De qi as multiple unique sensa-
tions at the needle site itself and around the site of
needle manipulation, including soreness, aching, numb-
ness, tingling, and even warmth [17,18]. The parameters
for electroacupuncture for LI15 (Jian Yu) and LI11 (Qu
Chi), St36 (Zu San Li) and Sp6 (San Yin Jiao) are set as
follows: intermittent wave, low-frequency (2 Hz); the
intensity is within the scope that patients can tolerate.
Huatuo brand needles (size 0.25 mm × 40 mm) were
manufactured by Suzhou Medical Appliance in Suzhou,
Jiangsu Province China, with GB6805-2 Electro-Acu Stim-
ulators (Huayi Medical Supply & Equipment Co. Ltd,
Shanghai, China) used.No acupuncture treatment group
Patients in the control group will receive conventional
stroke rehabilitation care, which is the same as the acu-
puncture group. However, no acupuncture treatments
will be given during the study period. They will be
assessed at each visit.
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The patients will be carefully examined at baseline, re-
examined after one week of treatment, and again after
the last treatment (three weeks after first acupuncture).
There will be a four-week follow-up after completion of
the acupuncture treatment.
Baseline assessments
Baseline assessments will be conducted before randomi-
zation, including gender and age of patients, clinical syn-
drome (left or right hemiplegia), diseased location and
size, NIHSS and Fugl-Meyer assessment (FMA) scores,
cognitive impairment based on the Montreal cognitive
assessment (MoCA), and swallowing disorder according
to the standardized swallowing assessment.
Primary outcome measurement
The primary outcome measurement in the study is the
change in NIHSS scores for neurological deficit evalu-
ation. NIHSS is a standardized stroke severity scale used
to describe neurological deficits in stroke patients and it
strongly predicts the likelihood of a patient’s recovery
after stroke. The NIHSS comprises tests of 11 items in-
cluding the level of consciousness, best gaze, visual field,
facial palsy, motor arm, motor leg, limb ataxia, sensory
ability, best language, dysphagia, and neglect. Total
scores range from 0 to 42, with scores above 25 indicating
very severe neurological impairment, scores of 5 to 24
suggesting moderately severe to severe impairment, and
scores below 5 indicating mild impairment [19]. Assess-
ments will be conducted at baseline and at one, three and
four-weeks follow-up.
Secondary outcome measures
Fugl-Meyer Assessment (FMA) scale for motor func-
tion The FMA was developed as the first quantitative
evaluative instrument for measuring sensorimotor stroke
recovery, which includes an assessment of the upper
extremity (UE, 66 points) and lower extremity (LE, 34
points). The motor domain has well-established reliabil-
ity and validity as an indicator of motor impairment
severity across different stroke recovery time points [20].
The mini-mental state examination (MMSE) and
Montreal cognitive assessment (MoCA) for cognitive
function The MMSE, first introduced by Folstein and
colleagues in 1975[21], has become a standard tool for cog-
nitive assessment in the clinical setting. It is a 10-minute
bedside measure of impaired thinking in undeveloped, un-
educated, diseased, or very old populations. The summed
score of the individual items indicates the current severity
of cognitive impairment [22]. However, there are many
difficulties in detecting early dementia with the MMSE.
Most individuals meet clinical criteria for mild cognitiveimpairment (MCI), but have scores above 26 on the
MMSE, which is within the range for normal elderly indi-
viduals. To address this problem the MoCA was developed
as a tool to screen patients who present with mild cognitive
complaints and usually perform in the normal range on
the MMSE [23]. The MoCA is used as a screening tool for
MCI in baseline assessment in our study.
Video-fluoroscopic swallowing study (VFSS) for swal-
lowing ability evaluation The functional dysphagia scale
is based on the VFSS in stroke patients, which is a sen-
sitive and specific method for quantifying the severity of
dysphagia [24,25].
Incidence of adverse events The subjects will be re-
quested to voluntarily report information about adverse
events. All adverse events happening during the trial will
be recorded, such as pallor, sweating or dizziness, faint-
ing during acupuncture treatment, bleeding, local
hematoma, unbearable prickling, retained needle after
treatment, and continuous severe pain more than one
hour after acupuncture. The researcher will confirm the
occurrence of adverse events and record all details such
as the date of occurrence, time, degree, measurement re-
lated to the treatment, and causal relationship with the
treatment. Serious adverse events will be reported to the
principal investigator immediately.
Quality control
The trial protocol has been reviewed and revised by ex-
perts on acupuncture, neurology, rehabilitation, statis-
tics, and methodology several times. Before the trial, all
staff are required to attend a series of training sessions.
These sessions will ensure that the personnel involved
fully understand the research protocol and standard op-
erating procedures for the study. During the trial super-
visors will check on case reports and acupuncture
operation twice per month. The research team will meet
regularly (once every three months) throughout the trial
to discuss progress, including recruitment, withdrawals,
treatment compliance, and adverse events. Economic
compensation and health education are also considered
as methods for improving compliance. A Data and Safety
Monitoring Board was set up on 10 May 2012 to monitor
the performance and safety of the trial.
Sample size calculation
The primary efficacy parameter is the change in NIHSS
scores from baseline to the end of treatment after three
weeks. According to our preliminary test and previous
study [26], the decrease in NIHSS score was conserva-
tively estimated to be 5 in the acupuncture group and 3
in the control group, with a standard deviation of 5.0. A
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Approximately 100 participants in each group were
calculated to be required. Estimating a 20% dropout rate,
each group will require 125 initial participants.
Statistical analysis
All data will be analyzed by a blinded statistician using
the SPSS(Statistical Product and Service Solutions)
statistical package program (version 17.0, SPSS Inc.,
Chicago, Illinois, United States) at a separate location
from the clinical research institute of Zhejiang Provincial
Hospital of Chinese medicine. Baseline data will be col-
lected and compared first. All patients randomized to each
group are included in the analysis and the data analysis
will be conducted using two-sided significance tests at the
5% significance level. The analysis of swallowing disorder
and cognitive impairment will be made on the defined
population of corresponding dysfunction in the baseline
assessment. Different statistics are presented differently;
for example, continuous variables will be expressed as
mean ± SD, t-test will be used for comparisons of two
independent samples, and non-parametric tests will be
used for variables that do not follow a normal distribution.
A P value of less than 0.05 (α value of 0.05) is considered
to indicate statistical significance. A safety analysis will be
performed by analyzing the frequency of adverse events
suspected as related to the treatment. The data for adverse
events are collected through the symptoms reported
by the patients, and observations by a researcher at
every visit.
Discussion
Acupuncture is widely accepted by Chinese people and
it is increasingly requested by patients and their relatives
in Western countries. Stroke is one of the most common
diseases for which acupuncture treatment is recom-
mended, according to the World Health Organization
[27]. However, Cochrane reviews have shown that
although acupuncture appeared to be safe, there is no
clear evidence of benefit. The number of patients in
existing trials is too small to be certain whether acu-
puncture is effective for the treatment of acute ische-
mic stroke. Larger, methodologically sound trials are
required [16,28].
For clinical trials blinding is difficult for acupuncture
so real randomized placebo-controlled trials seem impos-
sible. In Western medical hospitals in China, acupuncture
is used less for stroke compared with Chinese medical hos-
pitals, so setting up a no acupuncture control is feasible.We will conduct our trial in three Western medicine hos-
pitals to ensure a sufficient source of subjects and compli-
ance of the control group. Because many stroke patients
will ask for traditional Chinese medicine and acupuncture
treatment during the recovery period, we have set the
follow-up period as only four weeks.
Under strict quality control, this study could poten-
tially confirm whether or not acupuncture (including
scalp acupuncture and electroacupuncture) is an effective
adjunct to the standard rehabilitation therapy for acute
stroke. Our study may also confirm if acupuncture can be
effective in promoting the recovery of motor function
and is beneficial to swallowing disorder and cognitive
impairment.
Trial status
Participant enrollment is started from 1 March 2012.
Enrollment and trial completion are expected to be
finished by the end of June 2014.
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